D
SAB Biotherapeutics, Inc. SABS
$2.19 $0.13956.79% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -- -- -62.39% -- 207.72%
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -62.39% -- 207.72%
Cost of Revenue 2.56% -6.00% 78.05% 94.81% 86.29%
Gross Profit -6.67% -6.33% -88.78% -184.50% -83.39%
SG&A Expenses -24.91% -25.65% -83.39% 35.32% 25.61%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -7.00% -12.67% -47.22% 71.61% 59.47%
Operating Income 4.60% 5.43% 46.97% -112.47% -57.52%
Income Before Tax -37.88% -3.40% 50.15% -102.84% -6.61%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -37.88% -3.40% 50.15% -102.84% -6.61%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -37.88% -3.40% 50.15% -102.84% -6.61%
EBIT 4.60% 5.43% 46.97% -112.47% -57.52%
EBITDA 2.07% -6.25% 48.56% -138.44% -63.78%
EPS Basic -37.29% -2.85% 63.73% -14.80% 41.92%
Normalized Basic EPS -37.28% -2.85% 63.65% -14.81% 41.92%
EPS Diluted -37.29% -2.85% 63.73% -14.80% 41.92%
Normalized Diluted EPS -37.28% -2.85% 63.65% -14.81% 41.92%
Average Basic Shares Outstanding 0.43% 0.54% 37.43% 76.68% 83.55%
Average Diluted Shares Outstanding 0.43% 0.54% 37.43% 76.68% 83.55%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --